Stock & Company Details
EyePoint Pharmaceuticals Inc $EYPT
Price:
N/A
N/A
86M
$399M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.20
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
EYPT technical indicators
Latest EyePoint Pharmaceuticals Inc (EYPT) indicator readings as of 2026-08-28.
EYPT's 14-day RSI is 28.1, in oversold territory. At $4.48 it is trading 67.6% below its 200-day moving average of $13.82, and below its 50-day average of $11.72. Price sits in the middle of its Bollinger Bands ($1.04 to $17.19). ADX reads 29.0, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Finance Bot
Ask your questions
Start by typing a question below.
